Health Care: Drugs

Orexigen Therapeutics Inc (OREX: NASDAQ)

$3.37 n/a | n/a%
04/28/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 3.37
52 Week High 6.49
52 Week Low 1.65
Avg. Daily Vol. (Mil) 0.41
Beta (3 year) 2.90
Share Related Items
Mkt Cap (Mil) 37.90
Shares Out (Mil) 11.25
Float (Mil) 10.58
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.60
Current Ratio 3.40
LT Debt/ Equity 2.91
Total Debt / Equity 2.91
Valuation Ratios
Price Earnings n.a.
Price/Sales 1.12
Price/Book 0.66
Price/Cash Flow -2.40
Per Share Data
Earnings -1.68
Sales 3.00
Book Value 5.07
Cash Flow -1.42
Business Summary
Orexigen Therapeutics Inc is a biopharmaceutical company engaged in development of pharmaceutical product candidates for the treatment of obesity. Its product Contrave used for chronic weight management in adults.
General Information
3344 North Torrey Pines Cour
Suite 200
La Jolla, CA 92037
Industry : Drugs
Sector: Health Care
Employees: 132
CEO: Michael A. Narachi
Short Interest
Current Month (Mil) 2.98
Previous Month (Mil) 2.93
Short Interest Ratio (Days) 10.30
Management Effectiveness
Return on Equity n.a.
Return on Assets -8.10
Return on Investments -11.00
Gross Margin 91.80
EBIT Margin -49.10
Profit Margin -72.80

Portfolios with OREX

Latest OREX Headlines from TheStreet

More Financial News for OREX

Press Releases for OREX

See All Press Releases

Partner Headlines for OREX

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter